Skip to main content

Table 3 Mean annual per-cat ectoparasiticide doses purchased by USA cat owners and mean months of flea and tick coverage provided1

From: Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA

Product prescribed

Bravecto® Topical Solution

(n = 27,440)

Frontline® Gold

(n = 10,607)

Advantage II®

(n = 3583)

Doses purchased (Mean ± SD)

1.52 ± 0.90a

3.58 ± 3.02b

2.81 ± 2.77b

Months F/Ta coverage per year (Mean ± SD)

4.20 ± 1.58a

3.58 ± 1.61b

2.81 ± 1.35b

  1. 1Numbers with different superscripts differ significantly. Mean months of coverage were significantly different between Bravecto Topical and Frontline Gold (t(38,045) = 34.1481, P < 0.0001) as well as Bravecto Topical and Advantage II (t(31,021) = 50.3001, P < 0.0001)